Khurum Khan

1 ta ish

Institute of Cancer Research

1. miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial

   Gayathri Anandappa, Andrea Lampis, David Cunningham +24

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.419961